Hikma Pharmaceuticals (HKMPY) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free HKMPY Stock Alerts $46.50 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendHeadlinesShort InterestStock AnalysisChartDividendHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineWith 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big gunsfinance.yahoo.com - April 15 at 2:38 AMHikma shares spike after pharma giant’s profit up 30 per centmsn.com - February 22 at 1:34 PMHikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facilityprnewswire.com - February 21 at 1:20 PMHikma Pharmaceuticals USA Inc.: Hikma announces US launch of COMBOGESIC IVfinanznachrichten.de - February 5 at 8:04 AMHikma Pharma Launches Pain Relief Injection COMBOGESIC IV In USmarkets.businessinsider.com - February 5 at 8:04 AMHikma announces US launch of COMBOGESIC® IVfinance.yahoo.com - February 5 at 8:04 AMActiv Surgical Announces Completion of First International Procedure Using Its ActivSight™ Intelligent Lightfinance.yahoo.com - January 22 at 8:53 AMGuardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africafinance.yahoo.com - January 8 at 5:24 AMHikma Pharmaceuticals PLC's (LON:HIK) institutional investors lost 5.8% over the past week but have profited from longer-term gainsfinance.yahoo.com - November 6 at 7:37 AMSK Biopharm inks license deal with Hikma's Middle East unitmsn.com - August 17 at 10:15 PMHikma Pharmaceuticals outperforms market despite losses on the daymarketwatch.com - August 15 at 5:14 PMHikma Pharmaceuticals goes ex dividend tomorrowmsn.com - August 8 at 2:57 PMIs It Worth Considering Hikma Pharmaceuticals PLC (LON:HIK) For Its Upcoming Dividend?finance.yahoo.com - August 6 at 3:48 AMHikma Trims Full-Year Revenue Guidance After Advair Diskus Delaythestreet.com - June 27 at 8:21 AMHikma exceeds 150 injectable medicines in the US with launch of Dobutamine Injection, USPfinance.yahoo.com - June 15 at 5:46 PMFTSE 100: Ocado at risk, IMI in – how London Stock Exchange is set to reshuffle the indexuk.finance.yahoo.com - May 31 at 7:38 AMHikma Pharmaceuticals rises Friday, still underperforms marketmarketwatch.com - May 5 at 12:41 PMHikma Pharmaceuticals rises Wednesday, outperforms marketmarketwatch.com - May 3 at 1:31 PMHikma Pharmaceuticals Full Year 2022 Earnings: EPS Misses Expectationsfinance.yahoo.com - March 19 at 8:09 AMHikma Pharmaceuticals PLC (HIK)uk.investing.com - February 7 at 8:38 AMHikma Pharmaceuticals rises Tuesday, outperforms marketmarketwatch.com - January 31 at 12:47 PMHikma Pharmaceuticals falls Tuesday, underperforms marketmarketwatch.com - January 24 at 12:41 PMJunshi inks licensing deal with Hikma for toripalimab; FDA filing still under reviewmsn.com - December 27 at 8:33 AMJunshi Biosciences and Hikma Sign Exclusive Licensing Agreement for Cancer Treatment Drug Toripalimab for the Middle East and North Africa Regionfinancialpost.com - December 26 at 3:54 AMHikma Pharmaceuticals rises Thursday, outperforms marketmarketwatch.com - December 15 at 2:06 PMHikma Pharmaceuticals PLC (HKMPY)finance.yahoo.com - October 9 at 9:06 PMHKMPY.PK - | Stock Price & Latest News | Reutersreuters.com - September 28 at 5:47 PMHikma Pharmaceuticals PLC (H5P.F)uk.finance.yahoo.com - September 25 at 7:59 PMHikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the USfinance.yahoo.com - August 30 at 7:56 AMHikma Pharmaceuticals (OTC:HKMPY), Analyst Ratings, Price Targets, Predictionsbenzinga.com - July 17 at 12:22 AMDrugmaker Hikma's CEO Olafsson to step downnews.yahoo.com - May 24 at 4:20 AMInvestors in Hikma Pharmaceuticals (LON:HIK) have unfortunately lost 26% over the last yearfinance.yahoo.com - May 14 at 4:49 AMHikma completes acquisition of Custopharmfinance.yahoo.com - April 21 at 9:45 AMHikma gets preliminary approval from FTC to acquire Custopharmseekingalpha.com - April 20 at 7:38 AMHikma confirms FTC preliminary approval for Custopharmfinance.yahoo.com - April 20 at 2:11 AMU.S. FTC approves Hikma deal for Custopharm with conditionsfinance.yahoo.com - April 19 at 3:12 PMAnalysts Have Made A Financial Statement On Hikma Pharmaceuticals PLC's (LON:HIK) Yearly Reportfinance.yahoo.com - February 27 at 8:01 AMThose who invested in Hikma Pharmaceuticals (LON:HIK) five years ago are up 62%finance.yahoo.com - November 9 at 4:08 AMHikma donates 50,000 doses of injectable naloxone to help expand non-profit access to lifesaving treatment for reversing opioid overdosesfinance.yahoo.com - October 22 at 10:11 AMHikma Bolsters Injectable Portfolio With $375M Custopharm Acquisitionfinance.yahoo.com - September 27 at 1:47 PMHikma strengthens US Injectables business through acquisition of Custopharmfinance.yahoo.com - September 27 at 8:47 AM Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPY and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. HKMPY Media Mentions By Week HKMPY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HKMPY News Sentiment▼0.000.42▲Average Medical News Sentiment HKMPY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HKMPY Articles This Week▼00▲HKMPY Articles Average Week Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TGIFF News Today FFNTF News Today ABSCF News Today ACRDF News Today ACRHF News Today ALEAF News Today LBTSF News Today AZFL News Today ERBB News Today AVTBF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HKMPY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
